opioid vaccine

First-in-human Clinical Trial for a Vaccine to Treat Opioid Use Disorders Enrolls First Patients

September 8, 2021

The vaccine has been developed by researchers at the University of Minnesota Medical School.

Other News

OACA interns
Colton Cannon and Claire Knutson are working to observe how the recently implemented tiered huddle system is operating.
Two minds together
This marks the partnership's 18th year of spearheading new scientific ideas to improve the health of Minnesotans.
A Look Back at 2021
CTSI created a research infrastructure to improve, streamline, and facilitate the process of bench to bedside.